|Grant Affiliation:||Weiss: Protection by Neutralizing Antibodies|
|Strategy:||Combo: DNA & protein vaccines|
|Study Type:||Pre-Clinical Non-NHP|
|Study Start Date:||2011-03-10|
|Study Made Public:||2012-02-14|
Comparison of two adjuvants in ability to enhance antibody responses
CAVD 344 is preclinical rabbit study comparing two (2) adjuvants in the ability to enhance antibody responses.
Sign in to see full information about this study and to download study data.